Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /8049

Jilin Province Huinan Changlong Bio-pharmacy Company Ltd.

8049

• SHEK: 8049 • Delayed

2.52HKD 1.2%

0.3217 USD

As of 19 June 2026, Jilin Province Huinan Changlong Bio-pharmacy Company Ltd. has a market cap of $178.03M USD, ranking #21816 globally and #5782 in China. It ranks #1956 in the Healthcare sector, and #102 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

21816

Country Rank

5782

Sector Rank

1956

Industry Rank

102

Key Stats

Market Cap

$178.03MUSD

1.4B HKD

Enterprise Value

$80.36MUSD

629.5M HKD

Revenue (TTM)

$128.08MUSD

1.0B HKD

EBITDA (TTM)

$34.47MUSD

270.0M HKD

Net Income (TTM)

$28.25MUSD

221.32M HKD

EBITDA Margin

27%

Profit Margin

22%

PE Ratio

6.3

PS Ratio

1.4

PB Ratio

0.7

EV/EBITDA

2.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Hong Zhang open_in_new

Employees

1,107

Founded

1989

Website

jlchanglong.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.2%	3.3%	9.6%	23%	15%	16%	35%	56%	91%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	8049 吉林省辉南长龙生化药业股份有限公司 Class H ISIN: CNE100000130 Shares Out.: Shares Outstanding: 172.5M¹ Shares Float: 128.984M² TV: TradingView: HKEX: 8049 SA: Stock Analysis: HKG: 8049 YF: Yahoo Finance: 8049.HK GF: Google Finance: HKG: 8049 BA: Barron's: 8049 MS: Morningstar: XHKG: 08049	2.52 HKD	TV: TradingView: HKEX: 8049 SA: Stock Analysis: HKG: 8049 YF: Yahoo Finance: 8049.HK GF: Google Finance: HKG: 8049 BA: Barron's: 8049 MS: Morningstar: XHKG: 08049

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jilin Province Huinan Changlong Bio-pharmacy Company Ltd.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It markets its products under the Changlong and Qing Tong brands. The company also engages in the manufacture and distribution of beverages and prepackaged food. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.88B 107.34B CNY 9K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.11B 61.6B CNY 5K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.23B 35.33B CNY 3K%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 2K%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 2K%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 1K%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.2B 108.92B ILS 21K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 17K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.25B 1.06T INR 6K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.13B 1.05T INR 6K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.73B 7.57B EUR 5K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.53B 807.02B INR 5K%	23.1	India

chevron_leftBack